MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,325 | -4.7% | 75 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $18,170 | -100.0% | 75 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $87,096,770 | +4237.5% | 300,075 | +1166.1% | 21.01% | +6927.4% |
| Q4 2021 | $2,008,000 | +6.2% | 23,700 | 0.0% | 0.30% | +124.8% |
| Q3 2021 | $1,890,000 | -17.9% | 23,700 | +0.2% | 0.13% | -28.5% |
| Q2 2021 | $2,303,000 | -16.8% | 23,654 | 0.0% | 0.19% | +100.0% |
| Q1 2021 | $2,768,000 | +5.2% | 23,654 | 0.0% | 0.09% | -19.8% |
| Q4 2020 | $2,630,000 | -84.0% | 23,654 | -82.9% | 0.12% | -90.3% |
| Q3 2020 | $16,451,000 | +14.2% | 138,554 | +8.9% | 1.19% | +3.7% |
| Q2 2020 | $14,411,000 | +435.1% | 127,254 | +215.5% | 1.15% | +465.0% |
| Q1 2020 | $2,693,000 | -79.6% | 40,334 | -72.1% | 0.20% | -90.5% |
| Q4 2019 | $13,190,000 | – | 144,770 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |